Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Toxoplasmosis vaccines: what we have and where to go?
Yizhuo Zhang, Dan Li, Shaohong Lu, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Immunization with Plant-based Vaccine Expressing Toxoplasma gondii SAG1 Fused to Plant HSP90 Elicits Protective Immune Response in Lambs
Lucía M. Campero, Ignacio Gual, Valeria A. Sander, et al.
Acta Tropica (2025) Vol. 262, pp. 107540-107540
Closed Access
Discovery of novel vaccine candidates based on the immunogenic epitopes derived from Toxoplasma membrane proteins
Seyyed Amir Hosseini, S.R. Bani Hashemi, Davood Siamian, et al.
Clinical and Experimental Vaccine Research (2025) Vol. 14, Iss. 1, pp. 86-86
Open Access
Toxoplasmose congénitale : le rôle clé de l’équipe officinale
Anne-Solène Naudon
Actualités Pharmaceutiques (2025) Vol. 64, Iss. 643, pp. 45-48
Closed Access
T-cell activation of Toxoplasma gondii positive donors by maltodextrin nanoparticles formulated with killed Toxoplasma gondii
Mónica Vargas-Montes, François Fasquelle, Néstor Cardona, et al.
BMC Infectious Diseases (2025) Vol. 25, Iss. 1
Open Access
N‐Glycoproteomics of the Apicomplexan Parasite Toxoplasma gondii
Vanessa Horn, Patricia Zarnovican, Birgit Tiemann, et al.
PROTEOMICS (2025)
Open Access
Designing a multi-epitope vaccine using Toxoplasma ROP5, ROP7, and SAG1 epitopes and immunogenicity evaluation against acute and chronic toxoplasmosis in BABL/c mice
Zeinab Moghadamizad, Abdolhossein Dalimi, Majid Pirestani, et al.
Microbial Pathogenesis (2025), pp. 107567-107567
Closed Access
RPA-CRISPR/Cas12a-LFA combined with a digital visualization instrument to detect Toxoplasma gondii in stray dogs and cats in Zhejiang province, China
Hao Sun, Jiyuan Fan, Hongkun Chu, et al.
Microbiology Spectrum (2024) Vol. 12, Iss. 7
Open Access | Times Cited: 4
TgVax452, an epitope-based candidate vaccine targeting Toxoplasma gondii tachyzoite-specific SAG1-related sequence (SRS) proteins: immunoinformatics, structural simulations and experimental evidence-based approaches
Hamidreza Majidiani, Mohammad M. Pourseif, Bahareh Kordi, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Modeling Toxoplasma gondii-gut early interactions using a human microphysiological system
Carlos J. Ramírez‐Flores, Nicole D. Hryckowian, Andrew N. Gale, et al.
PLoS neglected tropical diseases (2025) Vol. 19, Iss. 2, pp. e0012855-e0012855
Open Access
A meta-analysis and survey on the prevalence of Toxoplasma gondii infection in cats (Felis catus)
Mohd Ubaid, Umra Fatima Zuberi, Syed Muhammad Sarosh Ghalib, et al.
The Journal of Basic and Applied Zoology (2025) Vol. 86, Iss. 1
Open Access
Immunization with a novel mRNA vaccine, TGGT1_216200 mRNA-LNP, prolongs survival time in BALB/c mice against acute toxoplasmosis
Yizhuo Zhang, Dan Li, Yu Shen, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 10
Host-pathogen interactions mediated by extracellular vesicles in Toxoplasma gondii infection during pregnancy
Fernando Gómez‐Chávez, José M. Murrieta-Coxca, Heriberto Caballero-Ortega, et al.
Journal of Reproductive Immunology (2023) Vol. 158, pp. 103957-103957
Open Access | Times Cited: 8
Recent Advances in the Development of Adenovirus-Vectored Vaccines for Parasitic Infections
Cal Koger-Pease, Dilhan J. Perera, Momar Ndao
Pharmaceuticals (2023) Vol. 16, Iss. 3, pp. 334-334
Open Access | Times Cited: 7
A novel Toxoplasma gondii TGGT1_316290 mRNA-LNP vaccine elicits protective immune response against toxoplasmosis in mice
Dan Li, Yizhuo Zhang, Shiyu Li, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 7
Transforming parasites into their own foes: parasitic extracellular vesicles as a vaccine platform
Daniel Alfandari, Sharon Cadury, Mattia I. Morandi, et al.
Trends in Parasitology (2023) Vol. 39, Iss. 11, pp. 913-928
Closed Access | Times Cited: 7
Improved ELISPOT protocol for monitoring Th1/Th17 T-cell response following T.gondii infection
François Fasquelle, Anaïs-Camille Vreulx, Didier Betbeder
PLoS ONE (2024) Vol. 19, Iss. 5, pp. e0301687-e0301687
Open Access | Times Cited: 2
Role of 6‐phosphogluconate dehydrogenase enzyme 1 in growth and virulence of Toxoplasma gondii and development of attenuated live vaccine
Qinghong Guo, Xuefang Guo, Nuo Ji, et al.
Microbial Biotechnology (2023) Vol. 16, Iss. 10, pp. 1957-1970
Open Access | Times Cited: 4
Working towards the development of vaccines and chemotherapeutics against neosporosis—With all of its ups and downs—Looking ahead
Dennis Imhof, Kai Pascal Alexander Hänggeli, Maria Cristina Ferreira de Sousa, et al.
Advances in Parasitology/Advances in parasitology (2024), pp. 91-154
Closed Access | Times Cited: 1
“One Health” Goal: Novel Preliminary Study on Putative Pig Immuno-Genetic Resistance to <em>Toxoplasma gondii</em> and Serologi-Cal Survey in Central Italy Regions
Martina Torricelli, Anna Fratto, S. Costarelli, et al.
(2024)
Open Access | Times Cited: 1
Assessing the impact of preventative measures to limit the spread of Toxoplasma gondii in wild carnivores of Madagascar
Fidisoa Rasambainarivo, Santatra Randrianarisoa, Olivier A. Rasolofoniaina, et al.
Conservation Biology (2024)
Open Access | Times Cited: 1
A novel DNA vaccine encoding the SRS13 protein administered by electroporation confers protection against chronic toxoplasmosis
Ceren Gül, Aytül Gül, Tuğba Karakavuk, et al.
Vaccine (2024) Vol. 42, Iss. 24, pp. 126065-126065
Closed Access | Times Cited: 1
4D label-free proteomic analysis reveals key potential pathways of Toxoplasma invasion into the central nervous system
Zhaowen Ren, Zipeng Yang, Hao Yuan, et al.
International Immunopharmacology (2024) Vol. 138, pp. 112618-112618
Closed Access | Times Cited: 1
Heterologous immunization targeting the CST1 antigen confers better protection than ROP18 in mice
Gi-Deok Eom, Ki‐Back Chu, Jie Mao, et al.
Nanomedicine (2024), pp. 1-10
Closed Access | Times Cited: 1
Diseases Caused by and Behaviors Associated with Toxoplasma gondii Infection
Ginger K. H. Akins, João M. Furtado, Justine R. Smith
Pathogens (2024) Vol. 13, Iss. 11, pp. 968-968
Open Access | Times Cited: 1
A novel mRNA vaccine, TGGT1_278620 mRNA-LNP, prolongs the survival time in BALB/c mice with acute toxoplasmosis
Yizhuo Zhang, Shiyu Li, Hongkun Chu, et al.
Microbiology Spectrum (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top